Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseasesPRNewsWire • 01/07/26
Eli Lilly is in advanced talks to acquire Ventyx Biosciences for more than $1 billion, according to people familiar with the matterWSJ • 01/06/26
Are You Looking for a Top Momentum Pick? Why Eli Lilly (LLY) is a Great ChoiceZacks Investment Research • 01/06/26
Google Stock, Lilly And An Aviation Name Are Fund Managers' FavoritesInvestors Business Daily • 01/06/26
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & JohnsonZacks Investment Research • 01/06/26
Eli Lilly (LLY) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 01/05/26
LLY Up 28% in 3 Months: Is it the Right Time to Invest in the Stock?Zacks Investment Research • 01/05/26
Novo Nordisk's weight-loss pill is available. Here's why Lilly's and Viking's stocks are down.Market Watch • 01/05/26
Wall Street Analysts Think Lilly (LLY) Is a Good Investment: Is It?Zacks Investment Research • 01/05/26
Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in ChinaZacks Investment Research • 01/02/26